📰 Eceptor News
Page 169 - Eceptor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eceptor. Real-time updates on events, politics, business and more.
January 7, 2022
An experimental immunotherapy can temporarily reprogram patients' immune cells to attack a specific target via only a single injection of messenger RNA (mRNA), similar to the mRNA-based COVID-19 vaccines, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
January 7, 2022
A novel immunotherapy strategy using in vivo generation of transient engineered chimeric antigen receptor (CAR) T cells, through the delivery of modified mRNA, can reduce fibrosis and restore cardiac function in a mouse model of heart failure, researchers report.
January 7, 2022
A new study reported the neutralization of Omicron by a large panel of sera collected from convalescent early pandemic, Alpha, Beta, Gamma and Delta infected individuals, as well as among vaccinees receiving three doses of the Oxford/AstraZeneca (AZD1222) or the Pfizer BioNtech (BNT16b2) vaccines.
January 6, 2022
Researchers from King's College London have shown that there are variations in how a brain chemical called GABA regulates the processing of visual stimuli.
January 6, 2022
Memory B cells never forget recurrent viral exposures and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is no exception, according to a new medRxiv* preprint study.
January 6, 2022
Researchers explored the presence of coronavirus receptors in the glossopharyngeal and vagal cranial nerves.
January 6, 2022
The scientists in this study used pooled convalescent serum to examine the serologic response in a population at risk of infection.
January 6, 2022
New research recently unveiled the utility of melatonin and melatonin-derived medicines in reducing brain entry of severe acute respiratory syndrome coronavirus 2 and subsequently preventing long-term neurological consequences of coronavirus disease 2019.
January 6, 2022
In this experiment, the chemical probe SGC-CK2-1 inhibited virus replication at nanomolar concentration, showing a highly selective effect on the kinase.
January 6, 2022
A new study published in iScience reports the results of a screening strategy to identify small molecules that target viral entry to block infection with this virus.